Danziten (nilotinib), FDA Approved for Treatment of Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Available at Biologics by McKesson
Biologics by McKesson became the sole specialty pharmacy provider for Danziten, a nilotinib formulation for adults with Philadelphia chromosome-positive chronic myeloid leukemia.